Pulsed Electric Field Ablation for Metastatic Breast Cancer

This is a phase I trial of the safety of image-guided pulsed electric field (PEF) ablation for the locoregional treatment of superficial soft tissue lesions in adults with metastatic breast cancer using the AliyaTM Pulsed Electric Field System.

Trial Details

NCT ID
NCT07487844
Phase
NA
Sponsor
University of California, San Francisco
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Pulsed Electric Field (PEF) System
  • Questionnaires
  • Tumor Ablation
Locations (sample)
  • San Francisco, California, United States|37.77493,-122.41942

Key Eligibility Criteria

  • Participants must have histologically or cytologically confirmed metastatic breast cancer.
  • Confirmed documented soft tissue involvement via imaging or biopsy, with at least one measurable lesion with a cutaneous and/or subcutaneous compon…
  • There are no limits on the amount of prior or concurrent anti-cancer therapies, but patients must be medically able (in the opinion of referring pr…
  • Age ≥18 years

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →